Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

strides pharma science limited - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride capsules, usp are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride capsules, usp are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. influenza a prophylaxis amantadine hydrochloride capsules, usp are indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. influenza a treatment amantadine hydrochloride capsules, usp are also indicated in the treatment of uncomplicated resp

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

epic pharma llc - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride capsules, usp are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride capsules, usp are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. amantadine hydrochloride capsules, usp are indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. amantadine hydrochloride capsules, usp are also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza a virus strains especially when administered early in the course of illness. there are no well-controlled clinical studies demonstrating that treatment with amantadine hydrochloride capsules, usp will avoid the development of influenza a virus pneumonitis or other complications in high risk patients. there is no clinical evidence indicating that amantadine hydrochloride capsules, usp are effective in the prophylaxis or treatment of viral respiratory tract illnesses other than those caused by influenza a virus strains. the following points should be considered before initiating treatment or prophylaxis with amantadine hydrochloride capsules, usp. amantadine hydrochloride capsules, usp are indicated in the treatment of idiopathic parkinson’s disease (paralysis agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. it is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. in the treatment of parkinson’s disease, amantadine is less effective than levodopa, (-)-3-(3,4-dihydroxyphenyl)-l-alanine, and its efficacy in comparison with the anticholinergic antiparkinson drugs has not yet been established. amantadine hydrochloride, usp is indicated in the treatment of drug-induced extrapyramidal reactions. although anticholinergic-type side effects have been noted with amantadine when used in patients with drug-induced extrapyramidal reactions, there is a lower incidence of these side effects than that observed with the anticholinergic antiparkinson drugs. amantadine hydrochloride capsules, usp are contraindicated in patients with known hypersensitivity to amantadine hydrochloride or to any of the other ingredients in amantadine hydrochloride capsules, usp.

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

chartwell rx, llc - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride oral solution is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride oral solution is also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. influenza a prophylaxis amantadine hydrochloride oral solution is indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine hydrochloride oral solution does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine hydrochloride oral solution prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. influenza a treatment amantadine hydrochloride oral solution is al

Կանադա - անգլերեն - Health Canada

mylan pharmaceuticals ulc - amantadine hydrochloride - capsule - 100mg - amantadine hydrochloride 100mg - adamantanes

Կանադա - անգլերեն - Health Canada

pharmel inc - amantadine hydrochloride - capsule - 100mg - amantadine hydrochloride 100mg - adamantanes

Կանադա - անգլերեն - Health Canada

pharmel inc - amantadine hydrochloride - syrup - 10mg - amantadine hydrochloride 10mg - adamantanes

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - amantadine hydrochloride - oral solution - 10mg/1ml

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

northumbria pharma ltd - amantadine hydrochloride - oral solution - 10mg/1ml

Կանադա - անգլերեն - Health Canada

odan laboratories ltd - amantadine hydrochloride - syrup - 10mg - amantadine hydrochloride 10mg

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. influenza a prophylaxis amantadine hydrochloride capsules are indicated for  chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. influenza a treatment amantadine hydrochloride capsules are also indicated in the treatment of uncomplicated respiratory tract illne